Search
Close this search box.

December 13, 2021

RECENT POSTS

ADVERTISEMENT

Junshi Biosciences and Coherus Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer

Junshi Biosciences and Coherus to meet with US FDA to discuss 1L NSCLC BLA supplement submission SHANGHAI, China and REDWOOD CITY, Calif., Dec. 13, 2021 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd. (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced positive results of an interim analysis

Control Measures for the Opening of Higher Education

Training Centres, IBTE’s, public and private higher education institutions, the premises will operate through the implementation of the Whole School Modification Approach and guided by the Endemic Phase Guidelines for Public and Private Higher Educatio…

Second Stage of Learning via Face-To-Face

The second stage of teaching and learning will be implemented starting the 17th of January 2022, if there is no increase in the number of serious infection cases reported among students, teachers and school staff while at school as well as based on the…

Face To Face Learning

By prioritizing fully vaccinated students, the Minister of Education explained that in order to attend school with face to face learning, the teaching and learning will be implemented in 2 Stages in which the first stage will commence on the 3rd of Jan…